Fulcrum Therapeutics (FULC) Assets Average (2019 - 2025)
Historic Assets Average for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $221.8 million.
- Fulcrum Therapeutics' Assets Average fell 2260.18% to $221.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.8 million, marking a year-over-year decrease of 2260.18%. This contributed to the annual value of $259.2 million for FY2024, which is 702.61% up from last year.
- According to the latest figures from Q3 2025, Fulcrum Therapeutics' Assets Average is $221.8 million, which was down 2260.18% from $235.7 million recorded in Q2 2025.
- Over the past 5 years, Fulcrum Therapeutics' Assets Average peaked at $310.7 million during Q2 2023, and registered a low of $143.0 million during Q1 2021.
- Moreover, its 5-year median value for Assets Average was $245.1 million (2024), whereas its average is $239.1 million.
- Per our database at Business Quant, Fulcrum Therapeutics' Assets Average surged by 8048.62% in 2021 and then tumbled by 2260.18% in 2025.
- Fulcrum Therapeutics' Assets Average (Quarter) stood at $245.3 million in 2021, then fell by 3.27% to $237.2 million in 2022, then rose by 13.08% to $268.3 million in 2023, then grew by 0.59% to $269.9 million in 2024, then decreased by 17.79% to $221.8 million in 2025.
- Its Assets Average stands at $221.8 million for Q3 2025, versus $235.7 million for Q2 2025 and $251.7 million for Q1 2025.